Clinical effects and mechanism of action of sumatriptan in migraine
- 31 December 1992
- journal article
- review article
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 94, 73-77
- https://doi.org/10.1016/0303-8467(92)90028-2
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Oral sumatriptan in acute migraineThe Lancet, 1991
- Evidence for 5-HT1B/1D Receptors Mediating the Antimigraine Effect of Sumatriptan and DihydroergotamineCephalalgia, 1991
- Migraine pain associated with middle cerebral artery dilatation: reversal by sumatriptanThe Lancet, 1991
- Self-Treatment of Acute Migraine with Subcutaneous Sumatriptan Using an Auto-Injector DeviceEuropean Neurology, 1991
- A Randomized, Double-Blind Comparison of Sumatriptan and Cafergot in the Acute Treatment of MigraineEuropean Neurology, 1991
- Evaluation of a Multiple-Dose Regimen of Oral Sumatriptan for the Acute Treatment of MigraineEuropean Neurology, 1991
- Sumatriptan An Oral Dose-Defining StudyEuropean Neurology, 1991
- Vasoactive peptide release in the extracerebral circulation of humans during migraine headacheAnnals of Neurology, 1990
- GR 43175: A preferential 5‐HT1D agent in monkey and human brains as shown by autoradiographySynapse, 1989
- Ergot alkaloids block neurogenic extravasation in dura mater: Proposed action in vascular headachesAnnals of Neurology, 1988